Axogen (AXGN) Deferred Taxes (2016 - 2017)
Axogen (AXGN) posted Deferred Taxes of -$29051.0 for Q4 2017, down 449.17% on a QoQ basis from -$5290.0 in Q3 2017, and down 345.05% year-over-year from $11855.0 in Q4 2016.
Powered by 
Analysis
Axogen (AXGN) Deferred Taxes (2016 - 2017) Analysis & Trends
Axogen has reported Deferred Taxes for 2 years, with the latest figure at -$29051.0 in Q4 2017.
- On a quarterly basis, Deferred Taxes fell 345.05% year-over-year to -$29051.0 in Q4 2017; TTM through Dec 2017 was -$20443.0, a N/A change from a year earlier, with the FY2017 full-year figure at $70316.0, up 299.93% from the prior year.
- Deferred Taxes was -$29051.0 for Q4 2017 at Axogen, down from -$5290.0 in the prior quarter.
- The five-year high for Deferred Taxes was $11855.0 in Q4 2016, with the low at -$29051.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -300,000.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 600,000.00 |
| 10 | Axogen | 2.51 Bn | 2.40 Bn | 50.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -29,051.00 |
| Sep 30, 2017 | -5,290.00 |
| Dec 31, 2016 | 11,855.00 |
| Sep 30, 2016 | 2,043.00 |